Parexel Strengthens Real World Research Offering
September 04, 2024 09:55 ET
|
Parexel International LLC
DURHAM, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel’s Near-Term Greenhouse Gas Reduction Targets Validated by Science Based Target Initiative (SBTi)
August 12, 2024 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Releases 2023 Environmental, Social and Governance Report
July 29, 2024 08:55 ET
|
Parexel International LLC
DURHAM, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients
April 25, 2024 06:59 ET
|
Parexel International LLC
DURHAM, N.C. and DENVER, April 25, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards
April 04, 2024 09:00 ET
|
Parexel International LLC
DURHAM, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Announces CEO Succession Plan
March 18, 2024 09:05 ET
|
Parexel International LLC
DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Appoints Susan R. Salka to Board of Directors
February 01, 2024 09:00 ET
|
Parexel International LLC
DURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance
January 10, 2024 08:55 ET
|
Parexel International LLC
DURHAM, N.C. and TOKYO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Named “Best Contract Research Organization” at 19th Annual Scrip Awards
November 17, 2023 07:30 ET
|
Parexel International LLC
DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree
November 08, 2023 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...